Dublin, April 12, 2023 (GLOBE NEWSWIRE) -- The "Infertility Drugs Market Size, Share & Trends Analysis Report By Drug Class (Gonadotropins, Aromatase Inhibitors, SERMs, Dopamine Agonists) By End-user (Men, Women), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
The global infertility drugs market size is expected to reach USD 5.6 billion by 2030 expanding at a CAGR of 6.1% from 2023 to 2030.
Companies Mentioned
- Bayer AG
- Novartis AG
- Merck & Co., Inc.
- Ferring B.V.
- Pfizer Inc.
- Mankind Pharma
- Teva Pharmaceutical Industries LTD.
- Sanofi
- Abbott
- Organon Group of Countries
The market seems to be saturated with fewer opportunities for new entrants. The companies including Merck & Co. Inc., Ferring B.V., and Organon group of companies holds majority of market share. Thus, the pharmaceutical companies are focusing on developing biosimilar of gonadotropins for market penetration.
For instance, Qilu Pharmaceutical Co., Ltd. focuses on developing QL1012, a recombinant human follicle stimulating hormone which is under phase 3 clinical trial. Successful completion of of trial and subsequent launch is anticipated to drive market.
Increasing initiatives undertaken by public and private organizations to support patients living with infertility are expected to positively contribute to infertility treatment market growth. For instance, in March 2022, the French government introduced new IVF law under which single women and same sex-couple avail treatment free of cost under the country's national healthcare system.
In addition, in November 2022, Saudi Arabia's Health Insurance Council conducted studies with regard to the inclusion of medicines under medical insurance coverage. The successful completion of the study and inclusion of medication under insurance is anticipated to increase patient access to treatment, subsequently, increase demand for medicines over the forecast period.
Rising awareness about disease and its available medicines among patients and physicians is anticipated to increase the target population for the market. For instance, in September 2021, Mubadala Health and United Eastern Medical Services (UEMedical) organized the '3rd HealthPlus Middle East Fertility Conference with an aim to rise awareness about the advancements in the treatment of this conditions and its benefits among physicians and patients in Dubai.
Moreover, there are several initiatives undertaken by the national government worldwide to tackle low fertility rate issues and promote childbirth which may increase the demand for drugs. For instance, in August 2022, the South Korean Government announced a provision for a monthly allowance of USD 740 per new child born in the family with an aim to tackle the low fertility rate in the country and encourage childbirth.
Infertility Drugs Market Report Highlights
- By drug class, the gonadotropin segment accounted for the largest share of the market in 2022 and is anticipated to witness fastest growth over the forecast period. This can be attributed to the availability of FDA-approved gonadotropins for infertility conditions in the market
- Based on end-user, the women segment dominated the infertility drugs market in 2022 owing to the rising incidence of the diseases such as PCOS, HPV associated vaginal cancer, uterine fibroids in women. As per the cohort studies published, in April 2022, approximately 1.5% of all French women aged 20 to 49 years were diagnosed with this condition annually.
- Hospital pharmacy segment dominated the infertility drugs market in 2022. This growth can be attributed to an increase in inpatient visits for the diagnosis and consultation of this condition worldwide
- North America dominated the global market in 2022 owing to factors such as high awareness among healthcare professionals about infertility conditions, ease of availability of drugs, and an increase in disease prevalence.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 110 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $3680.76 Million |
| Forecasted Market Value (USD) by 2030 | $5600 Million |
| Compound Annual Growth Rate | 6.1% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Infertility Drugs: Market Variables, Trends, and Scope
3.1 Market Lineage Outlook
3.1.1 Women's Health Market
3.2 Penetration and Growth Prospect Mapping
3.3 Regulatory Landscape
3.4 Market Dynamics
3.5 Market Driver Analysis
3.5.1 Rising burden of infertility
3.5.2 Presence of strong product pipeline
3.5.3 Increasing funding for infertility R&D
3.6 Market Restraint Analysis
3.6.1. Unsupportive Government Regulations for Infertility Drugs
3.7 PESTEL Analysis
3.8 Industry Analysis-Porter's Five Forces
3.9 Pipeline Analysis
Chapter 4 Infertility Drugs Market: Segment Analysis, by Drug Class, 2018 - 2030 (USD Million)
4.1 Infertility Drugs Market: Drug Class Movement Analysis
4.2 Gonadotropins
4.2.1 Gonadotropins Market, 2018 - 2030 (USD Million)
4.2.2 Aromatase Inhibitors
4.2.2.1 Aromatase Inhibitors Market, 2018 - 2030 (USD Million)
4.2.3 Selective Estrogen Receptor Modulators (SERMs)
4.2.3.1 Selective Estrogen Receptor Modulators (SERMs) Market, 2018 - 2030 (USD Million)
4.2.4 Dopamine Agonists
4.2.4.1 Dopamine Agonists Market, 2018 - 2030 (USD Million)
4.2.5 Others
4.2.5.1 Others Market, 2018 - 2030 (USD Million)
Chapter 5 Infertility Drugs Market: Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)
5.1 Infertility Drugs Market: Distribution Channel Movement Analysis
5.2 Hospital Pharmacy
5.2.1 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
5.3 Specialty & Retail Pharmacy
5.3.1 Specialty & Retail Pharmacy Market, 2018 - 2030 (USD Million)
5.4 Online Pharmacy
5.4.1 Online Pharmacy Market, 2018 - 2030 (USD Million)
Chapter 6 Infertility Drugs Market: Segment Analysis, by End-User, 2018 - 2030 (USD Million)
6.1 Infertility Drugs Market: End-User Movement Analysis
6.2 Men
6.2.1 Men Market, 2018 - 2030 (USD Million)
6.3 Women
6.3.1 Women Market, 2018 - 2030 (USD Million)
Chapter 7 Infertility Drugs Market: Regional Estimates and Trend Analysis
Chapter 8 Infertility Drugs Market: Competitive Analysis
For more information about this report visit https://www.researchandmarkets.com/r/uhsd4a
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
